IP Library Granted Patent US 9,777,011
Granted Patent B2
US 9,777,011 · App. 15/058,420 · Granted Oct 3, 2017

Process for preparing oxycodone compositions

Inventors: Robert Chapman (Downingtown, PA); Lonn S. Rider (Foster, RI); Qi Hong (Sharon, MA); Donald Kyle (Yardley, PA); Robert Kupper (East Greenwich, RI)
Assignees: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.; RHODES TECHNOLOGIES
C07D489/08A61K9/14A61K9/20A61K9/2095A61K9/48A61K9/4833A61K31/485C07D489/02C07D489/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,777,011
App. No.
15/058,420
Granted
Oct 3, 2017
Kind
B2
Abstract

In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.

Claims (27)

1. A process for purifying a starting composition comprising: (a) oxycodone free base, oxycodone HCl or a mixture thereof, and (b) 14-hydroxycodeinone, comprising subjecting the composition to a hydrogenation reaction one or more times at a temperature between 40° C. and 100° C., wherein (i) each hydrogenation reaction is carried out for a time from 4 hours to 36 hours, and (ii) the total reaction time of all of the hydrogenation reactions is from 10 hours to 36 hours.

2. A process of claim 1 , wherein the starting composition comprises oxycodone free base and 14-hydroxycodeinone.

3. The process of claim 2 , wherein the starting composition further comprises 8α,14-dihydroxy-7,8-dihydrocodeinone.

4. A process of claim 3 , wherein the starting composition is subjected to conditions that promote an acid catalyzed dehydration of 8α,14-dihydroxy-7,8-dihydrocodeinone to 14-hydroxycodeinone, prior to or during one or more of the hydrogenation reactions.

5. The process of claim 4 , wherein 400 ppm or less of 8α,14-dihydroxy-7,8-dihydrocodeinone is present at the end of all of the hydrogenation reactions.

6. The process of claim 2 , wherein at least one of the hydrogenation reactions is carried out at a temperature from 40° C. to 85° C.

7. The process of claim 2 , wherein at least one of the hydrogenation reactions is carried out at a temperature from 75° C. to 85° C.

8. The process of claim 2 , wherein at least one of the hydrogenation reactions is carried out for a time from 4 hours to 10 hours.

9. The process of claim 2 , wherein at least one of the hydrogenation reactions is carried out for a time from 10 hours to 21.7 hours.

10. The process of claim 9 , wherein the hydrogenation reaction or reactions that are carried out for a time from 10 hours to 21.7 hour are carried out at a temperature from 75° C. to 85° C.

11. The process of claim 2 , wherein at least one of the hydrogenation reactions is carried out for a time from 21.7 hours to 36 hours.

12. The process of claim 2 , wherein the hydrogenation reaction is carried out more than one time.

13. The process of claim 2 , wherein less than 100 ppm of 14-hydroxycodeinone is present at the end of all of the hydrogenation reactions.

14. The process of claim 2 , wherein less than 10 ppm of 14-hydroxycodeinone is present at the end of all of the hydrogenation reactions.

15. A process of claim 1 , wherein the starting composition comprises oxycodone HCl and 14-hydroxycodeinone.

16. The process of claim 15 , wherein the starting composition further comprises 8α,14-dihydroxy-7,8-dihydrocodeinone.

17. The process of claim 16 , wherein 400 ppm or less of 8α,14-dihydroxy-7,8-dihydrocodeinone is present at the end of all of the hydrogenation reactions.

18. The process of claim 15 , wherein at least one of the hydrogenation reactions is carried out at a temperature from 40° C. to 85° C.

19. The process of claim 15 , wherein at least one of the hydrogenation reactions is carried out at a temperature from 75° C. to 85° C.

20. The process of claim 15 , wherein at least one of the hydrogenation reactions is carried out for a time from 4 hours to 10 hours.

21. The process of claim 15 , wherein at least one of the hydrogenation reactions is carried out for a time from 10 hours to 21.7 hours.

22. The process of claim 21 wherein the hydrogenation reaction or reactions that are carried out for a time from 10 hours to 21.7 hour are carried out at a temperature from 75° C. to 85° C.

23. The process of claim 15 , wherein at least one of the hydrogenation reactions is carried out for a time from 21.7 hours to 36 hours.

24. The process of claim 15 , wherein the hydrogenation reaction is carried out more than one time.

25. The process of claim 15 , wherein less than 100 ppm of 14-hydroxycodeinone is present at the end of all of the hydrogenation reactions.

26. The process of claim 15 , wherein less than 10 ppm of 14-hydroxycodeinone is present at the end of all of the hydrogenation reactions.

27. The process of claim 1 , wherein at least 1 kg of the crystalline oxycodone HCl is prepared.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2019
From: THE P.F. LABORATORIES, INC.; PURDUE PHARMA TECHNOLOGIES, INC.
To: PURDUE PHARMA L.P.
Reel/Frame 048936/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2016
From: CHAPMAN, ROBERT S.; RIDER, LONN S.; HONG, QI; KYLE, DONALD; KUPPER, ROBERT
To: EURO-CELTIQUE S.A.
Reel/Frame 039759/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2016
From: EURO-CELTIQUE S.A.
To: PURDUE PHARMA L.P.
Reel/Frame 039760/0056 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2016
From: PURDUE PHARMA L.P.
To: PURDUE PHARMA L.P.; P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.; RHODES TECHNOLOGIES
Reel/Frame 039760/0214 →
Continuity (13)
Continuation 14725210 · May 29, 2015
Continuation 13366755 · Feb 6, 2012
Continuation 12893681 · Sep 29, 2010
Continuation 12380800 · Mar 4, 2009
Continuation 11653529 · Jan 16, 2007
Continuation 11391897 · Mar 29, 2006
Continuation 11093626 · Mar 30, 2005
Provisional Application 60651778 · Feb 10, 2005
Provisional Application 60648625 · Jan 31, 2005
Provisional Application 60620072 · Oct 18, 2004
Provisional Application 60601534 · Aug 13, 2004
Provisional Application 60557492 · Mar 30, 2004
Related Publication 20160250204A1 · Sep 1, 2016